Description

Tired of treating symptoms?

Dive into the future of medicine with Dr. Panos Chrysanthopoulos (CDO at Morphocell Technologies and co-founder and director of weCANdev Consulting Group Inc. in Canada)!

Discover how iPSCs create personalized CAR-T cell therapies for chronic liver failure and explore the potential to phase out diseases like leukemia within the next 5-10 years.

Join us as we explore:

• CRISPR-Cas9: The DNA scissors rewriting the rules of medicine.
• iPSCs (Induced Pluripotent Stem Cells): The key to personalized, regenerative therapies.
• CAR-T Cell Therapy: Tailored immune responses to fight cancer.
• Quality by Design (QbD): Guaranteeing the safety and efficacy of next-gen treatments.
• Ethical considerations and equitable access: Navigating the future of gene editing responsibly.

Don't forget to leave us a review and follow us on Spotify, LinkedIn, X, TikTok, and YouTube (Giota Pimenidou). Visit our website at www.global-greek-influence.com for more engaging content!